Hester Biosciences Limited

2,456.7

INR
-39.85(-1.60%)
As of November 14, 2024 10:00:00 AM

Hester Biosciences Limited Share Price Information

24 hour Low and High

Low: 2436
High: 2609.6

All time High

3204.96

Price Change 1h

+₹-77.20 +-3.05%

Price Change 1d

+₹-77.20 +-3.05%

Price Change 1w

+₹-216.45 +-8.10%

Hester Biosciences Limited Market Information

Exchange

NSE

Market Cap

2029.18 Cr

About Hester Biosciences Limited Share

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, contagious bovine pleuropneumonia, CCPP, and lumpy skin diseases; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides seroprofiling kits; diagnostic labs for poultry flocks; and mastitis control programs for cattle; as well as engages in manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

642

CEO

Mr. Rajiv Dinesh Gandhi B.Com

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Hester Biosciences Limited Announces Resignation of Nikhil Jhanwar as Chief Financial Officer, Effective 29 November 2024
  • Hester Bio gets a booster shot of profit in slog overs — check dividend
  • Hester Bio Standalone June 2024 Net Sales at Rs 73.47 crore, down 8.56% Y-o-Y
  • Breakout stocks to buy or sell: Hester Biosciences to IMPAL — Sumeet Bagadia recommends five shares to buy today | Stock Market News
  • Hester Bio Surges 22% in 2 Days on Tech Transfer for Manufacturing Covaxin

FAQs

Hester Biosciences Limited

2,456.7

INR
-39.85(-1.60%)
As of November 14, 2024 10:00:00 AM

Hester Biosciences Limited Share Price Information

24 hour Low and High

Low: 2436
High: 2609.6

All time High

3204.96

Price Change 1h

+₹-77.20 +-3.05%

Price Change 1d

+₹-77.20 +-3.05%

Price Change 1w

+₹-216.45 +-8.10%

Hester Biosciences Limited Market Information

Exchange

NSE

Market Cap

2029.18 Cr

About Hester Biosciences Limited Share

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, contagious bovine pleuropneumonia, CCPP, and lumpy skin diseases; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides seroprofiling kits; diagnostic labs for poultry flocks; and mastitis control programs for cattle; as well as engages in manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

642

CEO

Mr. Rajiv Dinesh Gandhi B.Com

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Hester Biosciences Limited Announces Resignation of Nikhil Jhanwar as Chief Financial Officer, Effective 29 November 2024
  • Hester Bio gets a booster shot of profit in slog overs — check dividend
  • Hester Bio Standalone June 2024 Net Sales at Rs 73.47 crore, down 8.56% Y-o-Y
  • Breakout stocks to buy or sell: Hester Biosciences to IMPAL — Sumeet Bagadia recommends five shares to buy today | Stock Market News
  • Hester Bio Surges 22% in 2 Days on Tech Transfer for Manufacturing Covaxin

FAQs